Skip to main content
. 2021 Feb 20;10(1):235–249. doi: 10.1007/s40120-021-00234-7

Fig. 3.

Fig. 3

Pooled efficacy results. Percentage of participants reporting pain relief at 2 h post dose (a) and the rate of sustained pain relief from 2 to 24 h and 2 to 48 h post dose (b) in the pooled placebo and pooled ubrogepant 50 mg groups from ACHIEVE I and ACHIEVE II